{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:50:59Z","timestamp":1784566259341,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s12149-013-0749-x","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T11:25:14Z","timestamp":1372937114000},"page":"802-807","source":"Crossref","is-referenced-by-count":44,"title":["Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases"],"prefix":"10.1007","volume":"27","author":[{"given":"Hiroshi","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anri","family":"Inaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Kinuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"749_CR1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, Sch\u00f6pfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31:578\u201383.","journal-title":"Hum Pathol"},{"key":"749_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/clinchem\/47.1.74","volume":"47","author":"AJ Janckila","year":"2001","unstructured":"Janckila AJ, Takahashi K, Sun SZ, Yam LT. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem. 2001;47:74\u201380.","journal-title":"Clin Chem"},{"key":"749_CR3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/clinchem\/39.4.635","volume":"39","author":"J Risteli","year":"1993","unstructured":"Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 1993;39:635\u201340.","journal-title":"Clin Chem"},{"key":"749_CR4","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.eururo.2007.02.033","volume":"52","author":"M Lein","year":"2007","unstructured":"Lein M, Wirth M, Miller K, Eickenberg HU, Weissbach L, Schmidt K, et al. Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic acid for detection of bone metastases progression. Eur Urol. 2007;52:1381\u20137.","journal-title":"Eur Urol"},{"key":"749_CR5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1464-410X.2011.10192.x","volume":"109","author":"K Izumi","year":"2012","unstructured":"Izumi K, Mizokami A, Itai S, Shima T, Shigehara K, Miwa S, et al. Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis. BJU Int. 2012;109:394\u2013400.","journal-title":"BJU Int"},{"key":"749_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y","volume":"61","author":"MS Soloway","year":"1988","unstructured":"Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195\u2013202.","journal-title":"Cancer"},{"key":"749_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MNM.0b013e328335a5ed","volume":"31","author":"AG Zafeirakis","year":"2010","unstructured":"Zafeirakis AG, Papatheodorou GA, Limouris GS. Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases. Nucl Med Commun. 2010;31:249\u201353.","journal-title":"Nucl Med Commun"},{"key":"749_CR8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12149-012-0620-5","volume":"26","author":"H Horikoshi","year":"2012","unstructured":"Horikoshi H, Kikuchi A, Onoguchi M, Sj\u00f6strand K, Edenbrandt L. Computer-aided diagnosis system for bone scintigrams from Japanese patients: importance of training database. Ann Nucl Med. 2012;26:622\u20136.","journal-title":"Ann Nucl Med"},{"key":"749_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/dji002","volume":"97","author":"JE Brown","year":"2005","unstructured":"Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, et al. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97:59\u201369.","journal-title":"J Natl Cancer Inst"},{"key":"749_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cncr.23529","volume":"113","author":"A Lipton","year":"2008","unstructured":"Lipton A, Cook R, Saad F, Major P, Garnero P, Terpos E, et al. Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer. 2008;113:193\u2013201.","journal-title":"Cancer"},{"key":"749_CR12","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/1097-0142(20000615)88:12+<2952::AID-CNCR11>3.0.CO;2-M","volume":"88","author":"A Fontana","year":"2000","unstructured":"Fontana A, Delmas PD. Markers of bone turnover in bone metastases. Cancer. 2000;88:2952\u201360.","journal-title":"Cancer"},{"key":"749_CR13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4065\/82.8.917","volume":"82","author":"SH Tsai","year":"2007","unstructured":"Tsai SH, Chen CY, Ku CH, Janckila AJ, Yam LT, Yu JC, et al. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis. Mayo Clin Proc. 2007;82:917\u201326.","journal-title":"Mayo Clin Proc"},{"key":"749_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1442-2042.2008.02029.x","volume":"15","author":"C Ozu","year":"2008","unstructured":"Ozu C, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. Int J Urol. 2008;15:419\u201322.","journal-title":"Int J Urol"},{"key":"749_CR15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcb.10662","volume":"91","author":"Evan T Keller","year":"2004","unstructured":"Keller Evan T, Brown Julie. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem. 2004;91:718\u201329.","journal-title":"J Cell Biochem"},{"key":"749_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2012.01.037","volume":"62","author":"D Ulmert","year":"2012","unstructured":"Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index. Eur Urol. 2012;62:78\u201384.","journal-title":"Eur Urol"},{"key":"749_CR17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1200\/JCO.2011.36.5791","volume":"30","author":"ER Dennis","year":"2012","unstructured":"Dennis ER, Jia X, Mezheritskiy IS, Stephenson RD, Schoder H, Fox JJ, et al. Bone Scan Index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol. 2012;30:519\u201324.","journal-title":"J Clin Oncol"},{"key":"749_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"749_CR19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00259-008-0721-5","volume":"35","author":"M Sadik","year":"2008","unstructured":"Sadik M, Suurkula M, H\u00f6glund P, J\u00e4rund A, Edenbrandt L. Quality of planar whole-body bone scan interpretations\u2014a nationwide survey. Eur J Nucl Med Mol Imaging. 2008;35:1464\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-013-0749-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0749-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T19:33:08Z","timestamp":1596051188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-013-0749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s12149-013-0749-x","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}